Tolerability and efficacy of chemoimmunotherapy when administered with a corticosteroid-free anti-emetic regimen.

Tieri, Jay; Harris, Brent; Melikian, Lori; Bullington, Susan; Naville-Cook, Chad; Crawford, Brooke

Tieri, Jay; Harris, Brent; Melikian, Lori; Bullington, Susan; Naville-Cook, Chad; Crawford, Brooke.

Affiliation

Tieri J; Department of Pharmacy, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
Harris B; Department of Pharmacy, Veteran's Healthcare System of the Ozarks, Fayetteville, AR, USA.
Melikian L; Department of Pharmacy, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
Bullington S; University of Kentucky HealthCare, Lexington, KY, USA.
Naville-Cook C; Department of Pharmacy, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.
Crawford B; Department of Pharmacy, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA.

J Oncol Pharm Pract ; 29(7): 1661-1666, 2023 Oct.

Article in En | MEDLINE | ID: mdl-36544380

Subject(s)
Key words

Chemoimmunotherapy; Corticosteroids; antiemetics; immune checkpoint inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiemetics / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google